The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.0M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 695K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

10 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Discovery of novel BRD4 inhibitors by high-throughput screening, crystallography, and cell-based assays.EBI
Nanchang University
Bioactive constituents from the green alga Caulerpa racemosa.EBI
Nanchang University
Discovery of Dual Function Agents That Exhibit Anticancer Activity via Catastrophic Nicotinamide Adenine Dinucleotide Depletion.EBI
Nanchang University
Design, synthesis of novel benzimidazole derivatives as ENL inhibitors suppressing leukemia cells viability via downregulating the expression of MYC.EBI
Nanchang University
Discovery of novel ketoxime ether derivatives with potent FXR agonistic activity, oral effectiveness and high liver/blood ratio.EBI
Nanchang University
Synthesis and biological evaluation of aminobenzamides containing purine moiety as class I histone deacetylases inhibitors.EBI
Nanchang University
Rearranged Diels-Alder Adducts and Prenylated Flavonoids as Potential PTP1B Inhibitors from EBI
Nanchang University
Discovery of novel reversible monoacylglycerol lipase inhibitors via docking-based virtual screening.EBI
Nanchang University
Design and synthesis of novel dual-cyclic RGD peptides for αEBI
Nanchang University
Design and optimization of purine derivatives as in vivo active PDE10A inhibitors.EBI
Nanchang University